Inbal Benhar Bar-On

Title: Inbal Benhar Bar-On: Innovator in Eye Disease Treatment

Introduction

Inbal Benhar Bar-On is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of medical research, particularly in the treatment of eye diseases and disorders. His innovative work has led to the development of a unique patent that addresses critical issues in neuronal degeneration and nerve regeneration.

Latest Patents

Inbal Benhar Bar-On holds a patent titled "Human monocyte sub-population for treatment of eye diseases and disorders." This patent describes a monocyte subpopulation that is either low in or substantially devoid of CD3 cells, CD19 cells, CD56 cells, and optionally CD16 cells. The monocyte subpopulation is designed for use in inhibiting neuronal degeneration, protecting neurons from glutamate toxicity, or promoting nerve regeneration in the retina or optic nerve. This innovation is particularly relevant for treating inflammatory diseases, disorders, or conditions of the eye.

Career Highlights

Inbal is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic options for patients suffering from eye-related conditions.

Collaborations

Inbal collaborates with esteemed colleagues, including Michal Eisenbach-Schwartz and Ester Yoles, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.

Conclusion

Inbal Benhar Bar-On is a pioneering inventor whose work in the treatment of eye diseases showcases the importance of innovation in medical research. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.